SRY+ Derivative X Chromosome in a Female With Apparently Typical Sexual Development

Casey J. Brewer,Alyxis G. Coyan,Nicki Smith,Brittany Jones,Teresa A. Smolarek,Jie Liu

DOI: https://doi.org/10.1002/mgg3.70033

2024-11-17

Molecular Genetics & Genomic Medicine

Abstract:Molecular Genetics &Genomic Medicine, Volume 12, Issue 11, November 2024.

genetics & heredity

What problem does this paper attempt to address?

A case report of breast development as the first manifestation combined with 46, XY complete disorder of sex development

许晓琴,袁金娜,傅君芬,董关萍

DOI: https://doi.org/10.3760/cma.j.cn101070-20191224-01292

2021-01-01

Abstract:To report the process of diagnosis and treatment of 1 case with SRY gene mutation of 46, XY complete gonadal dysplasia, and to discuss the clinical characteristics, diagnosis and treatment of the disease.Due to clitoral enlargement for 8 months, a 9 years old girl was admitted to the Children′s Hospital Affiliated to Zhejiang University School of Medicine.Previously, she had early breast development, and suffered from high gonadotropin expression when she was 6 years and 4 months old.Physical examination: breast B3 stage, female vulva, clitoris hypertrophy, normal urethra, normal vaginal opening, slightly thick hymen ring, the development of pubic hair was 2 stages, and Prader score level 1.Laboratory data showed elevated levels of estradiol, testosterone, and human chorionic gonadotrophin.Genetic examination revealed that the chromosome karyotype was 46, XY and SRY gene detection was positive.Therefore, the patient was diagnosed with 46, XY complete gonadal dysplasia.Bilateral gonadectomy was performed, and the posto-perative pathological diagnosis was bilateral gonadoblastoma with left dysgerminoma.The tumor did not recur after che-motherapy.The etiology of early breast development needs to be carefully identified.Patients with sexual characteristics dysplasia need to accept the chromosome karyotype analysis and gene detection, and surgical exploration should be performed when necessary for a correct diagnosis as soon as possible.
Conventional and molecular cytogenetic analyses of a derivative X chromosome in amniocentesis

Yu-qin LUO,Yu-li QIAN,Yan ZHANG,Yu-ning ZHU,Chen-ming XU,Shi-ming LV

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2011.02.021

2011-01-01

Abstract:Objective To analyze the aberrant der(X) chromosome using conventional and molecular cytogenetic approaches in a fetus of second trimester and to discuss its clinical effect. Methods Conventional cytogenetic procedures (GTG and CBG banding) were performed on cultured amniotic fluid cells. Threecolor fluorescence in situ hybridization (FISH) consisting of X chromosome enumeration probes(CEPX),CEPY and Tel Xp/Yp was further performed to study the aberrant der(X) chromosome. Results Der(X)was a rare X/Y translocation. The final karyotypes of the fetus was designated as: 46, X, der (X) t (X ; Y)(p22.3;q11. 2).ishder(X)t(X;Y)(p22.3;q11. 2)(X/Ypter-, DXZ1+, DYZ1+)mat. Conclusion The combination of FISH and conventional cytogenetic techniques is a powerful tool to determine derivative chromosome and to offer an accurate genetic counseling. Identification of Xp; Yq rearrangement can help estimate the risk of fetus abnormalities and give a more precise prognosis.
Clinical, cytogenetic, and molecular analysis with 46,XX male sex reversal syndrome: case reports

Xuefeng Gao,Guian Chen,Jing Huang,Quan Bai,Nan Zhao,Minjie Shao,Liping Jiao,Yanling Wei,Liang Chang,Dan Li,Liping Yang

DOI: https://doi.org/10.1007/s10815-013-9939-7

2013-01-01

Journal of Assisted Reproduction and Genetics

Abstract:Purpose To investigate the clinical characteristics of different categories of sex-reversed 46,XX individuals and their relationships with chromosomal karyotype and the SRY gene. Methods Chromosome karyotyping for peripheral blood culture and multi-PCR and FISH were performed. Results Endocrinological data showed that their endocrine hormone levels were similar to that observed for Klinefelter syndrome, with higher FSH and LH levels and lower T levels. Chromosome karyotyping for peripheral blood culture revealed 46, XX complement for 11 males. Molecular studies showed that there were locus deletions at SY84, SY86, SY127, SY134, SY254 and SY255 in AZF on chromosome Y in 9 cases, with the SRY gene present at the terminus of the X chromosome short arm. In one case, besides 6 locus deletions in AZF, there was also SRY gene deletion. In another case, there were locus deletions only at SY254 and SY255, with SY84, SY86, SY127 SY134 loci and SRY present. Conclusions The majority (10/11) of 46,XX males were SRY positive, with the SRY gene translocated into the terminus of the X chromosome short arm. These patients were caused mainly by an X/Y chromosomal inter-change during paternal meiosis, leading to the differentiation of primary gonads into testes. Only a single patient (1/11) was SRY-negative, in which there might be some unknown downstream genes involved in sex determination.
[Clinical, Molecular and Cytogenetic Studies on 4 Patients with 46, XX (SRY Positive) Male Syndrome].

Xin-Yi Xia,Ying-Xia Cui,Hong-Yong Lu,Bin Yang,Guo-Hong Wang,Lian-Jun Pan,Bao-Shan Hou,Yi-Feng Ge,Yong Shao,Bing Yao,Yu-Feng Huang

DOI: https://doi.org/10.3969/j.issn.1009-3591.2007.12.010

2007-01-01

Abstract:OBJECTIVE:To analyze the clinical, molecular and cytogenetic features of 46, XX (SRY positive) male syndrome.METHODS:The clinical features of 4 patients with 46, XX (SRY positive) male syndrome were analyzed retrospectively. Karyotyping, FISH, PCR amplification of the SRY gene, and Y-chromosome microdeletion were performed to study their molecular cytogenetic features.RESULTS:The Four patients were all sociopsychologically males of short stature and came to hospital for infertility. Physical examination revealed that their testes were small in volume and soft in texture, but their penes were normal. Semen analyses showed complete azoospermia. Detection of serum sexual hormone suggested hypergonadotropic hypogonadism. All were karyotyped as 46, XX. Molecular analyses revealed the presence of the SRY gene and absence of AZFa, b and c of the Y chromosome. FISH analysis showed that SRY genes were translocated to Xp in 3 of the patients.CONCLUSION:Phenotypically 46, XX (SRY positive) male patients are males generally, for the presence of the SRY gene in the whole genome and azoospermia due to the deletion of AZF. The clinical characteristics of the patient include testis dysgenesis, infertility and short stature. The long arm of the Y chromosome might contain the gene associated with body height. Extensive molecular and cytogenetic studies on 46, XX male syndrome may help to elucidate its genotype-phenotype relation.
Unbalanced X;Y translocations carrying SRY in prenatal settings: Clinical, molecular, and cytogenetic analysis of three cases

Xijing Liu,Zhu Zhang,Xuan Zhang,Jiamin Wang,Jieni Jiang,Lingping Li,He Wang,Shanling Liu,Ting Hu

DOI: https://doi.org/10.1002/pd.6520

2024-01-12

Prenatal Diagnosis

Abstract:Background Generally, the translocation of SRY onto one of the X chromosomes leads to 46, XX testicular disorders of sex development, a relatively rare condition characterized by the presence of testicular tissue with a 46, XX karyotype. Three prenatal cases of unbalanced X; Y translocation carrying SRY were identified in this study. Methods Structural variants were confirmed using single nucleotide polymorphism array and chromosomal karyotyping. X chromosome inactivation (XCI) was also analyzed. Detailed clinical features of the three cases were collected. Results We identified two fetuses with maternal inherited unbalanced X; Y translocations carrying SRY and skewed XCI presenting with normal female external genitalia, and one fetus with de novo 46, XX (SRY+) and random XCI manifested male phenotypic external genitalia. Conclusion This study reports that cases with unbalanced X; Y translocations carrying SRY manifested a normal female external genitalia in a prenatal setting. We speculate that the skewed XCI mediates the silence of SRY. In addition, our study emphasizes that combining clinical findings with pedigree analysis is critical for estimating the prognosis of fetuses with sex chromosome abnormalities.

genetics & heredity,obstetrics & gynecology
An infertile male with apparent 45,X turned out to have 45,X,der(Y)t(Y;13)(q11.2;q12),-13: clinicopathologic and cytogenomic studies.

Ying-Xia Cui,Xin-Yi Xia,Lian-Jun Pan,Yun-Hua Wang,Bing Yao,Yu-Feng Huang

DOI: https://doi.org/10.1016/j.fertnstert.2007.01.097

IF: 6.7

2007-01-01

Fertility and Sterility

Abstract:To conduct clinicopathologic and cytogenomic diagnostics of an infertile male with a karyotype of 45,X.Case report.Research laboratory at a university hospital.A male with a karyotype of 45,X was diagnosed because of infertility, and his parents also were examined.None.Cytogenomics studies were performed by multiple polymerase chain reaction and fluorescent in situ hybridization.Testicular pathology results showed Sertoli cell-only syndrome, and the SC nodule tissue was diagnosed as angiolipomata. Thus, the patient's karyotype was reinterpreted to be 45,X,der(Y)t(Y;13)(q11.2;q12),-13.ish der(Y)(SRY+, DYZ3+, wcp13+). Analysis of DNA polymorphism showed that the chromosome X was of maternal origin.This is the first case reported with a 45,X,der(Y)t(Y;13)(q11.1;q12),-13, which will be useful for the infertility phenotype-molecular karyotype correlation.
Identification of an SRY-negative 46,XX infertility male with a heterozygous deletion downstream of SOX3 gene

Shengfang Qin,Xueyan Wang,Jin Wang

DOI: https://doi.org/10.1186/s13039-022-00580-7

2022-02-14

Abstract:Background: A male individual with a karyotype of 46,XX is very rare. We explored the genetic aetiology of an infertility male with a kayrotype of 46,XX and SRY negative. Methods: The peripheral blood sample was collected from the patient and subjected to a few genetic testing, including chromosomal karyotyping, azoospermia factor (AZF) deletion, short tandem repeat (STR) analysis for AMELX, AMELY and SRY, fluorescence in situ hybridization (FISH) with specific probes for CSP 18/CSP X/CSP Y/SRY, chromosomal microarray analysis (CMA) for genomic copy number variations(CNVs), whole-genome analysis(WGA) for genomic SNV&InDel mutation, and X chromosome inactivation (XCI) analysis. Results: The patient had a karyotype of 46,XX. AZF analysis showed that he missed the AZF region (including a, b and c) and SRY gene. STR assay revealed he possessed the AMELX in the X chromosome, but he had no the AMELY and SRY in the Y chromosome. FISH analysis with CSP X/CSP Y/SRY showed only two X centromeric signals, but none Y chromosome and SRY. The above results of the karyotype, FISH and STR analysis did not suggest a Y chromosome chimerism existed in the patient's peripheral blood. The result of the CMA indicated a heterozygous deletion with an approximate size of 867 kb in Xq27.1 (hg19: chrX: 138,612,879-139,480,163 bp), located at 104 kb downstream of SOX3 gene, including F9, CXorf66, MCF2 and ATP11C. WGA also displayed the above deletion fragment but did not present known pathogenic or likely pathogenic SNV&InDel mutation responsible for sex determination and development. XCI assay showed that he had about 75% of the X chromosome inactivated. Conclusions: Although the pathogenicity of 46,XX male patients with SRY negative remains unclear, SOX3 expression of the acquired function may be associated with partial testis differentiation of these patients. Therefore, the CNVs analysis of the SOX3 gene and its regulatory region should be performed routinely for these patients.
Alterations of sex determination pathways in the genital ridges of males with limited Y chromosome genes†

Eglė A Ortega,Quinci Salvador,Mayumi Fernandez,Monika A Ward

DOI: https://doi.org/10.1093/biolre/ioy218

2018-10-03

Biology of Reproduction

Abstract:We previously demonstrated that in the mouse only two Y chromosome genes are required for a male to produce an offspring with the help of assisted reproduction technologies (ART): testis determinant Sry and spermatogonial proliferation factor Eif2s3y. Subsequently, we have shown that the function of these genes can be replaced by transgenic overexpression of their homologs, autosomally encoded Sox9 and X-chromosome encoded Eif2s3x. Males with Y chromosome contribution limited to two (XEif2s3yOSry), one (XEif2s3yOSox9 and XOSry,Eif2s3x), and no genes (XOSox9,Eif2s3x) produced haploid germ cells and sired offspring after ART. However, despite successful assisted reproductive outcome, they had smaller testes and displayed abnormal development of the seminiferous epithelium and testicular interstitium. Here we explored whether these testicular defects originated from altered pro-testis and pro-ovary factor signaling in genital ridges at the time of sex determination. Timed pregnancies were generated to obtain transgenic XEif2s3yOSry, XEif2s3yOSox9, XOSry,Eif2s3x, XOSox9,Eif2s3x, and wild-type XX and XY fetuses at 12.5 days post coitum. Dissected genital ridges were assessed for their morphology and anatomy, and expression of pro-testis and pro-ovary transcripts. All transgenic males displayed incomplete masculinization of gonadal shape, impaired development of testicular cords and gonadal vasculature, and decreased expression of factors promoting male pathway. Fetal gonad masculinization was more effective when sex determination was driven by the Sry transgene, in the presence of Y chromosome genes, and to a lesser extent a double dosage of X genes. The study adds to the understanding of the role of Y chromosome genes and their homologs during sex determination.

biology
Sex Reversal Syndrome (SRS): A Case of SRY-Positive 46,XX Testicular Disorder

Kishore Shil,Tahmina Ferdousi,Tahniyah Haq,M A Hasanat,Kishore Kumar Shil,,Tahmina Ferduosi,MA Hasanat

DOI: https://doi.org/10.15605/jafes.038.02.09

2023-11-16

Journal of the ASEAN Federation of Endocrine Societies

Abstract:We report a case of an SRY-positive 46,XX Indian male who presented with small testis and phallus, poor beard and mustache development and gynecomastia at the age of 24 years. He was biochemically found to have hypergonadotropic hypogonadism. He had 46,XX karyotype and Quantitative Fluorescence-PCR (QF-PCR) identified the SRY gene on the X chromosome. SRY-positive 46 XX male SRS cases usually present as phenotypically male since birth but develop features of hypogonadism, poor testicular development, and infertility after puberty. Infertility, hypogonadism, external genital development, and psychological distress are the major concerns during the management of the patients. Testosterone therapy for hypogonadism, artificial reproductive technologies for fertility, surgical repair of hypospadias/ cryptorchidism/under-virilized genitalia and psychological and genetic counseling are helpful for proper management of the patients.
46, XY gonadal dysgenesis: new SRY point mutation in two siblings with paternal germ line mosaicism

S Stoppa-Vaucher,T Ayabe,J Paquette,N Patey,D Francoeur,J-M Vuissoz,J Deladoëy,M E Samuels,T Ogata,C L Deal

DOI: https://doi.org/10.1111/j.1399-0004.2011.01832.x

Abstract:Familial recurrence risks are poorly understood in cases of de novo mutations. In the event of parental germ line mosaicism, recurrence risks can be higher than generally appreciated, with implications for genetic counseling and clinical practice. In the course of treating a female with pubertal delay and hypergonadotropic hypogonadism, we identified a new missense mutation in the SRY gene, leading to somatic feminization of this karyotypically normal XY individual. We tested a younger sister despite a normal onset of puberty, who also possessed an XY karyotype and the same SRY mutation. Imaging studies in the sister revealed an ovarian tumor, which was removed. DNA from the father's blood possessed the wild type SRY sequence, and paternity testing was consistent with the given family structure. A brother was 46, XY with a wild type SRY sequence strongly suggesting paternal Y-chromosome germline mosaicism for the mutation. In disorders of sexual development (DSDs), early diagnosis is critical for optimal psychological development of the affected patients. In this case, preventive karyotypic screening allowed early diagnosis of a gonadal tumor in the sibling prior to the age of normal puberty. Our results suggest that cytological or molecular diagnosis should be applied for siblings of an affected DSD individual.
SRY-positive 45,X/46,XY karyotype in a phenotypically Turner-like Chinese adolescent female with ovarian dysgerminoma and gonadoblastoma

Jiahong Zhou,Ping Zhan,Yang Cheng,Qing Luo,Li Chai,Lan Yuan,Xidan Zhu,Jinbo Liu

DOI: https://doi.org/10.1515/jpem-2023-0448

2024-07-09

Abstract:Objectives: 45,X/46,XY mosaicism is a rare condition with clinical and genetic heterogeneity and have a greatly increased risk of developing germ cell tumors. We describe a rare 45,X/46,XY Chinese girl with malignant tumors, especially focusing on the molecular genetics of gonadal tumor. Case presentation: We report a phenotypically Turner-like Chinese adolescent girl who presented primary amenorrhea and a pelvic mass as the chief complaint, which finally demonstrated dysgerminoma replacing the left gonad and gonadoblastoma arising from right gonad respectively. Her chromosome karyotype was 45,X(4)/46,XY(46); Y-chromosome microdeletions in AZFb regions were found on gonadal DNA rather than peripheral blood lymphocyte (PBL) DNA, while no variants were found in the promoter and coding region of SRY gene in both PBL and gonadal tissues. She underwent bilateral gonadectomy; no recurrence or serious complications were identified after 3 years of follow-up. Conclusions: This case emphasizes the probable correlation between Y chromosome microdeletions in gonadal tissue and the severity of the phenotype in patients with 45,X/46,XY mosaicism and highlights the importance of clinical genetic testing at the chromosomal and molecular level.
SRY gene detection and etiological analysis of patients with sex differentiation abnormality

Rong HE,Xiao-yi LIU,Xiao-su XIAO,Yong-qiang WANG,Fei-xue HU

DOI: https://doi.org/10.3760/cma.j.issn.1007-1245.2008.16.001

2008-01-01

Abstract:目的探讨SRY基因在性别分化和发育中的作用.方法应用染色体核型分析和聚合酶链式反应(PCR)对人类性别决定区域(SRY)基因进行特异性扩增.结果在18例患者中有5例为46,XY,SRY(+)睾丸女性化综合征患者;4例为46,XX女性性反转患者,其中3例为SRY(+),1例SRY(-);2例为46,XX,SRY(+)两性畸形患者;2例为47,XXY克氏征;其他5例患者SRY基因与染色体性别一致,但都伴有不同程度的性发育异常.结论 SRY基因的缺失或易位是导致性分化异常的最主要原因,同时性别决定和分化还有其他相关基因参与。
Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9

Brittany Croft,Thomas Ohnesorg,Jacqueline Hewitt,Josephine Bowles,Alexander Quinn,Jacqueline Tan,Vincent Corbin,Emanuele Pelosi,Jocelyn van den Bergen,Rajini Sreenivasan,Ingrid Knarston,Gorjana Robevska,Dung Chi Vu,John Hutson,Vincent Harley,Katie Ayers,Peter Koopman,Andrew Sinclair

DOI: https://doi.org/10.1038/s41467-018-07784-9

IF: 16.6

2018-12-01

Nature Communications

Abstract:Disorders of sex development (DSDs) are conditions affecting development of the gonads or genitalia. Variants in two key genes, SRY and its target SOX9, are an established cause of 46,XY DSD, but the genetic basis of many DSDs remains unknown. SRY-mediated SOX9 upregulation in the early gonad is crucial for testis development, yet the regulatory elements underlying this have not been identified in humans. Here, we identified four DSD patients with overlapping duplications or deletions upstream of SOX9. Bioinformatic analysis identified three putative enhancers for SOX9 that responded to different combinations of testis-specific regulators. All three enhancers showed synergistic activity and together drive SOX9 in the testis. This is the first study to identify SOX9 enhancers that, when duplicated or deleted, result in 46,XX or 46,XY sex reversal, respectively. These enhancers provide a hitherto missing link by which SRY activates SOX9 in humans, and establish SOX9 enhancer mutations as a significant cause of DSD.

multidisciplinary sciences
Increased Expression of Bypasses to Drive 46,XX Testicular Development: A New Mechanism of 46,XX DSD

Leah Ragno,Louisa Pyle,Daphne Yang,Trisha R. Bhatti,Jonathan Bradfield,Diane K. Bowen,Katheryn L. Grand,Hakon Hakonarson,Thomas F. Kolon,Joseph Glessner,M. Celeste Simon,Nicolas Skuli,Maria G. Vogiatzi,Marie A. Guerraty,Matthew A. Deardorff

DOI: https://doi.org/10.1101/2024.05.27.24307993

2024-05-28

Abstract:We present a patient with a novel cause of 46,XX ambiguous/androgenous genitalia Differences of Sex Development (DSD). Genome-wide array from blood showed 46,XX with ~35% mosaic duplication of 76.5 Mb at chromosome 8q13.2-q24.3, containing 257 OMIM genes including and . Congenital adrenal hyperplasia testing was negative, testosterone was elevated, and the pro-testicular master regulator was absent. The infant had a uterus, one streak ovary (<5% 8q duplication), and one testicle (75% 8q duplication). We hypothesized that mosaic duplication resulted in localized ZFPM2 overexpression and testicular development. In typical testicular development, ZFPM2 and its binding partner, GATA4, drive expression of the master regulator. We completed RNA-seq of four Formalin-Fixed Paraffin-Embedded (FFPE) gonadal tissue samples from this mosaic individual to identify differentially expressed genes (DEGs). After quality control, two lines representing with and without the duplication were analyzed. In gonadal tissue containing the duplication, increased dosage of in a -negative-46-XX individual appears to upregulate transcriptional activity of gonadal specific promoters such as SOX9 and AMH via its protein interaction with known regulator of early testis development GATA4. SOX9 (FC=39.2, =6.1x10 ) and SF-1 (FC=1.4, =1.6x10 ) interact to produce the functional marker of fetal Sertoli cells, AMH (FC=108.4, =3.0x10 ), and inhibit female sexual differentiation. Several components of the testicular sex-development pathway were upregulated in addition to SOX9 and AMH, including the pro-testicular transcription factor MAP3K1 (FC=1.7, =5.6x10 ), DMRT1 (FC=13.9, =2.1x10 ), LHX9 (FC=2.5, =5.0x10 ), DHH (FC=12.0, =1.8x10 ), PTGDS (FC=2.5, =3.4x10 ), and SOX8 (FC=10.9, =6.5x10 ). may function as a master temporal and spatial regulator of mammalian testicular organogenesis whose increased dosage elicits significant and cascading downstream effects. Further, components of the ovarian WNT-signaling pathway were repressed, including LEF1 (FC=-3.7, =1.4x10 ) and FOXL2 (FC=-8.1, =2.9x10 ). We have shown that increased dosage can induce 46,XX testicular development in a manner not dependent on . This contravenes the previous understanding that GATA4/ZFPM2 drives testicular development through . may modulate numerous critical sex-development genes including transcription factors otherwise thought to be downstream of (MAP3K1, SOX9, AMH). Findings from this single high-yield patient demonstrate that the primary role of in testicular development may be independent of . This adds to the brief (<10) list of genes capable of directing testicular development in the 46,XX context, absent SRY. Overall, new understanding of these genes demonstrates that the role of SRY as a master regulator of testicular development may be less than previously thought.
Non-Invasive Prenatal Test Analysis Opens a Pandora's Box: Identification of Very Rare Cases of SRY-Positive Healthy Females, Segregating for Three Generations Thanks to Preferential Inactivation of the XqYp Translocated Chromosome

Cristina Politi,Katia Grillone,Donatella Nocera,Emma Colao,Michelle Li Bellisario,Sara Loddo,Giorgia Catino,Antonio Novelli,Nicola Perrotti,Iuliano Rodolfo,Paola Malatesta

DOI: https://doi.org/10.3390/genes15010103

IF: 4.141

2024-01-17

Genes

Abstract:The translocation of the testis-determining factor, the SRY gene, from the Y to the X chromosome is a rare event that causes abnormalities in gonadal development. In all cases of males and females carrying this translocation, disorder of sex development is reported. In our study, we described a peculiar pedigree with the first evidence of four healthy females from three generations who are carriers of the newly identified t(X;Y)(q28;p11.2)(SRY+) translocation with no evidence of ambiguous genitalia or other SRY-dependent alterations. Our study was a consequence of a Non-Invasive Prenatal Test (NIPT) showing a sexual chromosomal abnormality (XXY) followed by a chorionic villus analysis suggesting a normal karyotype 46,XX and t(X;Y) translocation detected by FISH. Here, we (i) demonstrated the inheritance of the translocation in the maternal lineage via karyotyping and FISH analysis; (ii) characterised the structural rearrangement via chromosomal microarray; and (iii) demonstrated, via Click-iT® EdU Imaging assay, that there was an absolute preferential inactivation of the der(X) chromosome responsible for the lack of SRY expression. Overall, our study provides valuable genetic and molecular information that may lead personal and medical decisions.

genetics & heredity
A conserved NR5A1-responsive enhancer regulates SRY in testis-determination

Denis Houzelstein,Caroline Eozenou,Carlos F. Lagos,Maëva Elzaiat,Joelle Bignon-Topalovic,Inma Gonzalez,Vincent Laville,Laurène Schlick,Somboon Wankanit,Prochi Madon,Jyotsna Kirtane,Arundhati Athalye,Federica Buonocore,Stéphanie Bigou,Gerard S. Conway,Delphine Bohl,John C. Achermann,Anu Bashamboo,Ken McElreavey

DOI: https://doi.org/10.1038/s41467-024-47162-2

IF: 16.6

2024-03-30

Nature Communications

Abstract:Abstract The Y-linked SRY gene initiates mammalian testis-determination. However, how the expression of SRY is regulated remains elusive. Here, we demonstrate that a conserved steroidogenic factor-1 (SF-1)/NR5A1 binding enhancer is required for appropriate SRY expression to initiate testis-determination in humans. Comparative sequence analysis of SRY 5’ regions in mammals identified an evolutionary conserved SF-1/NR5A1-binding motif within a 250 bp region of open chromatin located 5 kilobases upstream of the SRY transcription start site. Genomic analysis of 46,XY individuals with disrupted testis-determination, including a large multigenerational family, identified unique single-base substitutions of highly conserved residues within the SF-1/NR5A1-binding element. In silico modelling and in vitro assays demonstrate the enhancer properties of the NR5A1 motif. Deletion of this hemizygous element by genome-editing, in a novel in vitro cellular model recapitulating human Sertoli cell formation, resulted in a significant reduction in expression of SRY . Therefore, human NR5A1 acts as a regulatory switch between testis and ovary development by upregulating SRY expression, a role that may predate the eutherian radiation. We show that disruption of an enhancer can phenocopy variants in the coding regions of SRY that cause human testis dysgenesis. Since disease causing variants in enhancers are currently rare, the regulation of gene expression in testis-determination offers a paradigm to define enhancer activity in a key developmental process.

multidisciplinary sciences
A Case of Agonadism Associated with Y-Chromosome Rearrangement: Cytogenetic and Molecular Studies

Ying-Xia Cui,Yi-Chao Shi,Qi Liu,Xin-Yi Xia,Hong-Yong Lu,Hai-Feng Shao,Li Jia,Bing Yao,Yi-Feng Ge,Xiao-Jun Li,Yu-Feng Huang

DOI: https://doi.org/10.2164/jandrol.108.006353

2009-01-01

Andrology

Abstract:Testicular regression syndrome (MIM273250) is characterized primarily by absence of gonads in a person of XY karyotype. Phenotypes range from complete female external genitalia (primary or "true" agonadism) to male phenotype with anorchia (testicular regression). Phenotypic differences depend on the stage of embryo development during which testes degenerate. No conclusive mapping can be concluded for the phenotype. We describe a novel case of primary agonadism with a karyotype of 46,X,der(Y)(pter -> q11.23::pter -> p11.31 or p11.2:). Transcriptional analysis revealed little expression of USP9Y and UTY genes on the Y chromosome in our case, which would explain her phenotypes of agonadism with short stature.
Heterozygous Deletion of the SHOX Gene Enhancer in Two Females with Clinical Heterogeneity Associating with Skewed XCI and Escaping XCI

Yixi Sun,Yuqin Luo,Yeqing Qian,Min Chen,Liya Wang,Hongge Li,Yu Zou,Minyue Dong

DOI: https://doi.org/10.3389/fgene.2019.01086

IF: 3.7

2019-01-01

Frontiers in Genetics

Abstract:Skewed X-chromosome inactivation (XCI) plays an important role in the phenotypic heterogeneity of X-linked disorders. However, the role of skewed XCI in XCI-escaping gene SHOX regulation is unclear. Here, we focused on a heterozygous deletion of SHOX gene enhancer with clinical heterogeneity. Using SNP array, we detected that the female proband with Leri-Weill dyschondrosteosis (LWD) carried an 857 kb deletion on Xp22.3 (encompassing SHOX enhancer) and a 5,707 kb large-fragment deletion on Xq25q26. XCI analysis revealed that the X-chromosome with the Xq25q26 large-fragment deletion was completely inactivated, which forced the complete activation of the other X-chromosome carrying SHOX enhancer deletion. While the Xp22.3 deletion locates on the escaping XCI region, under the combined action of skewed XCI and escaping XCI, transcription of SHOX gene was mainly from the activated X-chromosome with SHOX enhancer defect, involving in the formation of LWD phenotype. Interestingly, this SHOX enhancer deletion was inherited from her healthy mother, who also demonstrated completely skewed XCI. However, the X-chromosome with SHOX enhancer deletion was inactivated, and the normal X-chromosome was activated. Combing with escaping XCI, her phenotype was almost normal. In summary, this study was a rare report of SHOX gene enhancer deletion in a family with clinical heterogeneity due to skewed inactivation of different X-chromosomes, which can help in the genetic counseling and prenatal diagnosis of disorders in females with SHOX defect.
[Genetic and clinical characteristics of 46,XX testicular disorders of sex development]

Qing-Lin Ye,Jian-Zheng Fang,Xiao-Yu Yang

Abstract:Objective: To investigate the genetic and clinical characteristics of 46, XX testicular disorders of sex development (DSD). Methods: We collected the clinical data on the patients with 46,XX testicular DSD diagnosed in the Center of Reproductive Medicine of the First Affiliated Hospital of Nanjing Medical University from January 2017 to January 2023, and analyzed their genetic and clinical characteristics and the SRY gene chromosomal location for those with SRY-positive. Results: A total of 26 patients were included in this study, all with 46,XX and deletion of the AZFa, b and c regions, with a mean height of (168.3±5.9) cm, body weight of (64.0±7.5) kg, BMI of (22.66±2.79) kg/m2, left testis volume of (2.53±1.16) ml and right testis volume of (2.74±1.34) ml. The semen volume of the patients averaged 1.35 (0.18－2.78) ml, FSH (36.85±18.01) IU/L, LH (19.71±9.71) IU/L, and T (6.08±2.71) nmol/L. The SRY-negative patients had a higher incidence rate of development disorders in the reproductive system than the SRY-positive ones (5/6 vs 3/20, P = 0.004), but no statistically significant differences were observed in the other parameters. The SRY gene was localized at the end of Xp in 13 of the 14 SRY-positive cases, and at chromosome 15 in the other 1. Conclusion: 46,XX testicular DSD has some similarity and heterogeneity in genetics and clinical characteristics.
A case of 49,XXXYY followed-up from infancy to adulthood with review of literature

Junko Kanno,Akinobu Miura,Sayaka Kawashima,Hirohito Shima,Dai Suzuki,Miki Kamimura,Ikuma Fujiwara,Masayuki Kamimura,Mitsugu Uematsu,Masataka Kudo,Atsuo Kikuchi

DOI: https://doi.org/10.1507/endocrj.EJ24-0015

2024-07-12

Abstract:49,XXXYY is an extremely rare sex chromosomal aneuploidy (SCA), with only seven cases reported worldwide to date. Among these cases, only three have been documented into adulthood. Moreover, no cases of 49,XXXYY have been reported in Japan. This SCA has been identified in two scenarios: in vitro fertilization and abortion. Similar to 47,XXY, this aneuploidy is a type of Klinefelter syndrome. Aneuploidy of the X chromosome can lead to various progressive complications due to excess X chromosomes. Herein, we present the case of a Japanese man with 49,XXXYY. He exhibited developmental delays and external genitalia abnormalities since early infancy but was not closely monitored for these symptoms until the age of 3 years old. At that time, a chromosome test revealed his karyotype to be 49,XXXYY. Subsequent examinations were conducted due to various symptoms, including delayed motor development, intellectual disability, facial dysmorphisms, forearm deformities, hip dysplasia, cryptorchidism, micropenis, primary hypogonadism, and essential tremor. Since reaching puberty, he has undergone testosterone replacement therapy for primary hypogonadism, experiencing no complications related to androgen deficiency to date. He has maintained normal lipid and glucose metabolism, as well as bone density, for a prolonged period. There are no other reports on the long-term effects of testosterone treatment for the SCA. Appropriate testosterone replacement therapy is recommended for individuals with 49,XXXYY to prevent complications. This report will contribute to an enhanced understanding of the 49,XXXYY phenotype, aiding in the diagnosis, treatment, and genetic counseling of future cases.

SRY+ Derivative X Chromosome in a Female With Apparently Typical Sexual Development

A case report of breast development as the first manifestation combined with 46, XY complete disorder of sex development

Conventional and molecular cytogenetic analyses of a derivative X chromosome in amniocentesis

Clinical, cytogenetic, and molecular analysis with 46,XX male sex reversal syndrome: case reports

[Clinical, Molecular and Cytogenetic Studies on 4 Patients with 46, XX (SRY Positive) Male Syndrome].

Unbalanced X;Y translocations carrying SRY in prenatal settings: Clinical, molecular, and cytogenetic analysis of three cases

An infertile male with apparent 45,X turned out to have 45,X,der(Y)t(Y;13)(q11.2;q12),-13: clinicopathologic and cytogenomic studies.

Identification of an SRY-negative 46,XX infertility male with a heterozygous deletion downstream of SOX3 gene

Alterations of sex determination pathways in the genital ridges of males with limited Y chromosome genes†

Sex Reversal Syndrome (SRS): A Case of SRY-Positive 46,XX Testicular Disorder

46, XY gonadal dysgenesis: new SRY point mutation in two siblings with paternal germ line mosaicism

SRY-positive 45,X/46,XY karyotype in a phenotypically Turner-like Chinese adolescent female with ovarian dysgerminoma and gonadoblastoma

SRY gene detection and etiological analysis of patients with sex differentiation abnormality

Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9

Increased Expression of Bypasses to Drive 46,XX Testicular Development: A New Mechanism of 46,XX DSD

Non-Invasive Prenatal Test Analysis Opens a Pandora's Box: Identification of Very Rare Cases of SRY-Positive Healthy Females, Segregating for Three Generations Thanks to Preferential Inactivation of the XqYp Translocated Chromosome

A conserved NR5A1-responsive enhancer regulates SRY in testis-determination

A Case of Agonadism Associated with Y-Chromosome Rearrangement: Cytogenetic and Molecular Studies

Heterozygous Deletion of the SHOX Gene Enhancer in Two Females with Clinical Heterogeneity Associating with Skewed XCI and Escaping XCI

[Genetic and clinical characteristics of 46,XX testicular disorders of sex development]

A case of 49,XXXYY followed-up from infancy to adulthood with review of literature